Tweet Thomas et al. Anoctamin-2-specific T cells link Epstein-Barrvirus to multiple sclerosis. Cell (2026), https://doi.org/10.1016/j.cell.2025.12.032 Epstein-Barr virus (EBV) infection constitutes a prerequisite for multiple sclerosis (MS) development, and cross-reactivity between EBV nuclear antigen 1 (EBNA1) and anoctamin-2 (ANO2) antibodies was previously demonstrated in persons with MS (pwMS). Here, we show that ANO2-specific CD4+ T cells…
Category: Multiple Sclerosis Research
Risk of MS among women drops by over 40% with greater vitamin D intake
A greater intake of vitamin D, from both food and supplements, was linked to a 42% lower risk of developing multiple sclerosis (MS) among women living in Norway, according to a large prospective study. “Our findings suggest that a higher dietary intake of vitamin D decreases the risk of developing MS,” the researchers wrote, noting…
Learning to be intentional about my relationship with food
For a long time, food was simply a necessity — something I grabbed between classes, appointments, or bouts of fatigue. I didn’t think much about how it made me feel, aside from the noticeable energy dips or sugar highs. Living with multiple sclerosis (MS) has gradually shifted my perspective, though. Over time, I’ve realized that…
Top 10 MS news stories of 2025
Throughout 2025, the team at Multiple Sclerosis News Today brought readers the latest advances and updates in research related to multiple sclerosis (MS). Here are the top 10 most-read news stories MSNT published this year. Source: irelandms.com
Making Plans on Your Terms
By Angel Blair I always considered myself a planner. I constantly made lists; I carefully thought out decisions, big or small, to get to the most optimal outcome. I loved comparing the pros and cons of possibilities for things to … Continue reading → Source: blog.mymsaa.org
Find gets new funding for treatment to repair damaged myelin
Find Therapeutics has secured CA$10 million (approximately $7.4 million) in funding to continue advancing tasronetide, its lead candidate for boosting myelin repair in people with multiple sclerosis (MS). The Series A extension financing round follows the completion of a Phase 1 trial in healthy volunteers, in which tasronetide was deemed safe and well tolerated. The…
Six to Watch..New Channels or a Repeat of the Same thing
Tweet Six trials to Watch. Four for BTKi, CD40-CD40L and CD19 and here they are sold as inhibitors of progressive disease, but in reality they are all B cell inhibitors. BTKi may not be B cell depleters and so far two have been abit not good in relapsing disease and two are not being tested…
Mild MS disability causes hidden workplace challenges, study finds
People with multiple sclerosis (MS) who have mild disability still experience several disease-related difficulties at work — challenges that can lead employees to shift to part-time or possibly quit their jobs — even after their condition is disclosed, a new study in Norway highlights. In particular, there are three key ways that even mild MS…
Life Reflections
There are many times when the memories from the past can blind us from where we are going in life. It is only natural for all humans to hold a grudge and not know the best way to release those emotions. Often, we let our past experiences dictate our future, and while this can sometimes…
Global experts outline new strategy to help prevent multiple sclerosis
A group of international experts has proposed a first-of-its-kind framework aimed at preventing multiple sclerosis (MS) from developing. Rather than focusing on a single cause, the framework outlines multiple opportunities to lower MS risk across a person’s life, from reducing childhood obesity and viral exposures to addressing smoking and low vitamin D levels in adulthood….